Over the last 12 months, Nuvalent insiders reported no purchases and 26 sales totaling $2.15B across SEC Form 4 filings. 42% of those filings were made under pre-arranged 10b5-1 trading plans.
Scroll the table sideways for price, value and marks.
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Jul 15, 2026 | Flynn James ED·10% | ▽ Sale to issuer | 17,251,894 | $124 | $2.14B | -100% | 4 tranches · indirect |
| Jul 15, 2026 | Meyers Michael L.D | ▽ Sale to issuer | 3,444 | — | — | -100% | — |
| Jul 15, 2026 | Balcom AlexandraChief Financial Officer · O | ▽ Sale to issuer | 55,450 | — | — | -100% | 2 tranches |
| Jul 15, 2026 | Srivastava SapnaD | ▽ Sale to issuer | 3,444 | — | — | -100% | — |
| Jul 15, 2026 | Oliger Christy J.D | ▽ Sale to issuer | 6,091 | — | — | -100% | — |
| Jul 15, 2026 | Squarer RonD | ▽ Sale to issuer | 6,281 | — | — | -100% | — |
| Jul 15, 2026 | Turner Christopher DurantChief Medical Officer · O | ▽ Sale to issuer | 55,450 | — | — | -100% | 2 tranches |
| Jul 15, 2026 | Noci DarleneChief Development Officer · O | ▽ Sale to issuer | 55,450 | — | — | -100% | 2 tranches |
| Jul 15, 2026 | Lane BenjaminSee Remarks · O | ▽ Sale to issuer | 36,553 | — | — | -100% | 2 tranches |
| Jul 15, 2026 | Pelish Henry E.Chief Scientific Officer · O | ▽ Sale to issuer | 55,450 | — | — | -100% | 2 tranches |
| Jul 15, 2026 | Porter James RichardPresident and CEO · O·D | ▽ Sale to issuer | 161,375 | — | — | -100% | 2 tranches |
| Jul 15, 2026 | Miller Deborah AnnChief Legal Officer · O | ▽ Sale to issuer | 55,450 | — | — | -100% | 2 tranches |
| Jul 15, 2026 | Protopapas AnnaD | ▽ Sale to issuer | 3,444 | — | — | -100% | — |
| Jul 15, 2026 | Bogle Grant C.D | ▽ Sale to issuer | 5,577 | — | — | -100% | — |
| Jul 15, 2026 | Wheeler CameronD | ▽ Sale to issuer | 3,444 | — | — | -100% | — |
| Jul 9, 2026 | Pelish Henry E.Chief Scientific Officer · O | ▼ Sale | 2,111 | $123.81 | $261K | -3.2% | plan |
| Jul 6, 2026 | Porter James RichardPresident and CEO · O·D | ▼ Sale | 30,000 | $123.72 | $3.7M | -8.5% | plan |
| Jul 1, 2026 | Noci DarleneChief Development Officer · O | ▼ Sale | 23,000 | $123.59 | $2.8M | -28.4% | plan |
| Jun 29, 2026 | Noci DarleneChief Development Officer · O | ▼ Sale | 5,500 | $123.51 | $679K | -8.6% | plan |
| Jun 9, 2026 | Noci DarleneChief Development Officer · O | ▼ Sale | 20,000 | $122.81 | $2.5M | -25.6% | plan |
| Jun 8, 2026 | Porter James RichardPresident and CEO · O·D | ▼ Sale | 30,000 | $88.53 | $2.7M | -8.5% | plan · 3 tranches |
| May 28, 2026 | Noci DarleneChief Development Officer · O | ▼ Sale | 100 | $109.76 | $11K | -0.2% | plan |
| May 28, 2026 | Noci DarleneChief Development Officer · O | ▼ Sale | 1,500 | $109.3 | $164K | -2.5% | plan |
| May 28, 2026 | Noci DarleneChief Development Officer · O | ▼ Sale | 1,178 | $108.01 | $127K | -1.9% | plan |
| May 28, 2026 | Noci DarleneChief Development Officer · O | ▼ Sale | 1,422 | $107.33 | $153K | -2.3% | plan |
| May 28, 2026 | Noci DarleneChief Development Officer · O | ▼ Sale | 1,300 | $106.26 | $138K | -2% | plan |
The same Form 4 data over REST or MCP, already grouped into events with the plan flag and the dollar value read. A free key does 100 calls a day and needs no card. Prefer email? Nuvalent filings can reach your inbox instead.
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. This page shows open-market activity: purchases (code P), sales (S) and dispositions back to the issuer (D). Scheduled compensation events such as stock grants and option exercises are also filed on Form 4 but carry no trading signal, so they are not shown and counts here can be lower than the raw EDGAR filing total. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $NUVL feed.